Skip to main content
SpringerLink
Log in

Medical Treatment: Treated vs. Untreated Glaucoma and Ocular Hypertension

  • Chapter
  • First Online:
Pearls of Glaucoma Management

  • 1292 Accesses

Abstract

Understanding the natural history of chronic disease is difficult, and for ethical reasons it is particularly difficult to study the natural history of an untreated disease for which beneficial treatment is available. The study design that is most amenable to assessing the natural history of a chronic disease is an observational cohort study. However, because of the large number of subjects and long time duration needed to obtain the answer of interest, conducting these studies may not be feasible. Data from other study designs are typically used to infer the natural history of chronic diseases. Such is the case with open angle glaucoma (OAG).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schoff EO, Hattenhauer MG, Ing HH, et al. (2001) Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology 108(5):882–6.

    Article  PubMed  CAS  Google Scholar 

  2. Mason RP, Kosoko O, Wilson MR, et al. (1989) National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 96(9):1363–8.

    CAS  Google Scholar 

  3. Wilson MR, Kosoko O, Cowan CL Jr, Crandall D, et al. (2002) Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol 134(3):399–405.

    Article  Google Scholar 

  4. Collaborative Normal Tension Glaucoma Study Group (1998) Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487–97.

    Google Scholar 

  5. Leske MC, Heijl A, Hyman L, et al. (1999) Early Manifest Glaucoma Trial: Design and baseline data. Ophthalmology 106:2144–53.

    Article  PubMed  CAS  Google Scholar 

  6. Heijl A, Leske MC, Bengtsson B, et al.; For the Early Manifest Glaucoma Trial Group (2002) Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–79.

    Google Scholar 

  7. Kass MA, Heuer DK, Higginbotham EJ, et al (2002) The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701–13; discussion 829–30.

    Article  PubMed  Google Scholar 

  8. Miglior S, Zeyen T, Pfeiffer N, et al.; European Glaucoma Prevention Study (EGPS) Group (2002) Results of the European Glaucoma Prevention Study. Ophthalmology 112(3):366–75.

    Google Scholar 

  9. Miglior S, Pfeiffer N, Torri V, et al.; European Glaucoma Prevention Study (EGPS) Group (2007) Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114(1):3–9.

    Google Scholar 

  10. Hattenhauer MG, Johnson DH, Ing HH, et al. (1998) The probability of blindness from open-angle glaucoma. Ophthalmology 105(11):2099–104.

    Article  PubMed  CAS  Google Scholar 

  11. .Anderson DR, Drance SM, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group (2001) Natural history of normal-tension glaucoma. Ophthalmology 108(2):247–53.

    Google Scholar 

  12. .Leske MC, Heijl A, Hussein M, et al.; Early Manifest Glaucoma Trial Group (2003) Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial. Arch Ophthalmol 121(1):48–56.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Colorado Denver, Rocky Mountain Lions Eye Institute, 1675 N. Ursula Street, Aurora, CO, 80045, USA

    Malik Y. Kahook

Authors
  1. Malik Y. Kahook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Roy Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Malik Y. Kahook .

Editor information

Editors and Affiliations

  1. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    JoAnn A. Giaconi

  2. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Simon K. Law

  3. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Anne L. Coleman

  4. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Joseph Caprioli

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kahook, M.Y., Wilson, M.R. (2010). Medical Treatment: Treated vs. Untreated Glaucoma and Ocular Hypertension. In: Giaconi, J., Law, S., Coleman, A., Caprioli, J. (eds) Pearls of Glaucoma Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68240-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68240-0_29

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-68238-7

  • Online ISBN: 978-3-540-68240-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation